{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:52:08Z","timestamp":1791251528716,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20720-2","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:15:14Z","timestamp":1791202514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgeons, Time to Step Up! Building Quality Surgical Evidence in Gastroenteropancreatic Neuroendocrine Tumors"],"prefix":"10.1245","author":[{"given":"L\u00e9amarie","family":"Meloche-Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"20720_CR1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-026-19712-z","author":"L Meloche-Dumas","year":"2026","unstructured":"Meloche-Dumas L, Bleicher J, Soreide K, et al. Mapping the evidence for surgical care of gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs): a scoping review. Ann Surg Oncol. 2026. https:\/\/doi.org\/10.1245\/s10434-026-19712-z.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"20720_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/bjs\/znac267","volume":"109","author":"S Partelli","year":"2022","unstructured":"Partelli S, Massironi S, Zerbi A, et al. Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. Br J Surg. 2022;109(12):1186\u201390.","journal-title":"Br J Surg"},{"key":"20720_CR3","doi-asserted-by":"publisher","first-page":"S1580","DOI":"10.1016\/j.annonc.2025.09.047","volume":"36","author":"S Partelli","year":"2025","unstructured":"Partelli S, Andreasi V, Zerbi A, et al. LBA36 Management of asymptomatic sporadic nonfunctioning pancreatic neuroendocrine neoplasms\u2009\u2264\u20092 cm: a prospective international observational multicentric cohort study (ASPEN study). Ann Oncol. 2025;36:S1580.","journal-title":"Ann Oncol"},{"issue":"9","key":"20720_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bjs\/znae178","volume":"111","author":"S Partelli","year":"2024","unstructured":"Partelli S, Landoni L, Bartolomei M, et al. Neoadjuvant 177Lu-DOTATATE for nonfunctioning pancreatic neuroendocrine tumours (NEOLUPANET) - a prospective single-arm trial. Br J Surg. 2024;111(9):17.","journal-title":"Br J Surg"},{"issue":"2","key":"20720_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S2468-1253(24)00406-0","volume":"10","author":"J Hallet","year":"2025","unstructured":"Hallet J, Falconi M, Partelli S, et al. Bridging gaps in surgical care for neuroendocrine tumours: CUTNETs begins. Lancet Gastroenterol Hepatol. 2025;10(2):111.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"20720_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/CCO.0000000000000746","volume":"33","author":"D Callegaro","year":"2021","unstructured":"Callegaro D, Raut CP, Swallow CJ, Gronchi A. Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group program: the transatlantic Australasian Retroperitoneal Sarcoma Working Group program. Curr Opin Oncol. 2021;33(4):301\u20138.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"20720_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371(3):224\u201333.","journal-title":"N Engl J Med"},{"key":"20720_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00701-3","author":"S Singh","year":"2024","unstructured":"Singh S, Halperin D, Myrehaug S, et al. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high\u2011dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024. https:\/\/doi.org\/10.1016\/S0140-6736(24)00701-3.","journal-title":"Lancet"},{"issue":"7","key":"20720_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa2403991","volume":"392","author":"JA Chan","year":"2025","unstructured":"Chan JA, Geyer S, Zemla T, et al. Phase 3 trial of cabozantinib to treat advanced neuroendocrine tumors. N Engl J Med. 2025;392(7):653\u201365.","journal-title":"N Engl J Med"},{"key":"20720_CR10","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1200\/JCO.2016.34.15_suppl.4005","volume":"34","author":"JR Strosberg","year":"2016","unstructured":"Strosberg JR, Wolin EM, Chasen B, et al. NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE. J Clin Oncol. 2016;34:4005\u20134005.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20720-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:06:26Z","timestamp":1791248786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20720-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":10,"alternative-id":["20720"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20720-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"2 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}